Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'pi3 kinase p110'

Search results for: 'pi3 kinase p110'

Items 31-40 of 208

Page
per page
  1. Saracatinib (AZD0530)
    A2133 Saracatinib (AZD0530)
     3 Citation
    Target: Src
    Summary: Src/Abl inhibitor,potent and selective
      ≥27.1 mg/mL
  2. PHA-665752
    A2307 PHA-665752
     1 Citation
    Target: c-MET
    Summary: C-Met inhibitor,potent and ATP-competitive
  3. NVP-BHG712
    A8683 NVP-BHG712
    Target: Eph Receptors|VEGFR
    Summary: EphB4 inhibitor,potent and selective
      ≥25.15 mg/mL
  4. Lapatinib
    A8218 Lapatinib
     2 Citation
    Target: ErbB
    Summary: EGFR/HER2 inhibitor,potent,selective and reversible
      ≥29.05 mg/mL
  5. BMS-777607
    A5703 BMS-777607
    Target: MET
    Summary: C-Met inhibitor, potent and selective
      ≥25.65 mg/mL
  6. Gefitinib (ZD1839)
    A8219 Gefitinib (ZD1839)
     3 Citation
    Target: EGFR
    Summary: Selective EGFR inhibitor
      ≥22.34 mg/mL
  7. BGJ398
    A3014 BGJ398
     1 Citation
    Target: FGFR
    Summary: FGFR inhibitor ,potent and selective
      insoluble in H2O; insoluble in EtOH; ≥7 mg/mL
  8. AZD4547
    A8350 AZD4547
    Target: FGFR
    Summary: FGFR inhibitor
      ≥23.2 mg/mL
  9. Afatinib (BIBW2992)
    A8247 Afatinib (BIBW2992)
     1 Citation
    Target: EGFR
    Summary: Irreversible EGFR/HER2 inhibitor
      ≥24.3 mg/mL
  10. PRT062607 Hydrochloride
    A3736 PRT062607 Hydrochloride
     1 Citation
    Target: Syk
    Summary: SYK inhibitor,potent and selective
      ≥21.5 mg/mL

Items 31-40 of 208

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 207item
Reversibility
  1. Reversible 19item
  2. Irreversible 3item
Target
  1. Cyclin-Dependent Kinases 17item
  2. Akt 1 item
  3. PI3K 11item
  4. Raf 7item
  5. Aurora Kinases 10item
  6. CSF-1R 2item
  7. mTOR 6item
  8. FLT3 8item
  9. GSK-3 7item
  10. PLK 4item
  11. Chk 5item
  12. Eph Receptors 2item
  13. VEGFR 19item
  14. PDGFR 14item
  15. c-Kit 6item
  16. RET 3item
  17. Bromodomain-containing proteins(BRDs) 1 item
  18. p38 6item
  19. PKB 1 item
  20. JNK 1 item
  21. SGK 1 item
  22. Bcr-Abl 8item
  23. MEK 3item
  24. FGFR 6item
  25. Pim 3item
  26. MET 5item
  27. Src 5item
  28. Trk Receptors 2item
  29. EGFR 9item
  30. ROCK 4item
  31. BTK 1 item
  32. PAK 3item
  33. FAK 4item
  34. BMP and Other Activin Receptors 2item
  35. JAK 7item
  36. Syk 5item
  37. DNA-PK 3item
  38. AMPK 2item
  39. PDHK 1 item
  40. ErbB 2item
  41. S6 kinases 1 item
  42. Adenosine Kinases 2item
  43. ERK 2item
  44. c-MET 5item
  45. PKC 4item
  46. Ubiquitin-specific proteases 1 item
  47. Ca2 /calmodulin-dependent protein kinases (CaMKs) 5item
  48. Lyn 1 item
  49. HER2 2item
  50. Pyk2 3item
  51. LRRK2 3item
  52. Insulin and Insulin-like Receptors 2item
  53. ALK 3item
  54. ROS1 1 item
  55. Sphingosine kinases (SphKs) 1 item
  56. Myosin light chain kinases (MLCKs) 1 item
  57. MELK 1 item
  58. Insulin-like growth factors (IGFs) 1 item
  59. MK2 2item
  60. Tie-2 2item
  61. RSK 1 item
  62. ATM/ATR 2item
  63. Farnesyl Diphosphate Synthases 1 item
  64. CK2 2item
  65. HIPK2 1 item
  66. HIPK3 1 item
  67. P2X Receptors 1 item
  68. P110 1 item
  69. Hck 1 item
  70. Insulin Receptors 1 item
  71. IRG-1R 1 item
  72. Cdc2-like kinase (Clk) 1 item
  73. eEF-2 1 item
  74. Cdc7 1 item
  75. ZAP-70 1 item
  76. c-RET 1 item
  77. p70 rsk 1 item
  78. TAM kinase 1 item
  79. AXL 1 item
  80. c-Fms tyrosine kinase 1 item
  81. MSK 1 item
  82. Lyn kinase 1 item
  83. ITK 1 item
  84. NUAK 1 item
  85. DCLK2 1 item
  86. PKD 1 item
  87. tropomyosin receptor kinase 1 item
  88. SK 1 item
  89. PIKfyve 1 item
  90. Insulin Receptor 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 15item
  3. Adrenocortical Carcinoma 2item
  4. Advanced Renal Cell Carcinoma 1 item
  5. Bladder Cancer 4item
  6. Bladder Carcinoma 1 item
  7. B-lymphoid Malignancies 1 item
  8. Breast Cancer 40item
  9. Cancer 140item
  10. Cervical Cancer 4item
  11. Cholangiocarcinoma 2item
  12. Chronic Lymphocytic Leukemia 2item
  13. Clear Cell Renal Cell Carcinoma 1 item
  14. Colon Cancer 17item
  15. Colon Carcinoma 2item
  16. Colorectal Cancer 18item
  17. Glioblastoma 16item
  18. Glioma 6item
  19. Hepatocellular Carcinoma 4item
  20. HIV Infections 1 item
  21. Immunological Diseases 1 item
  22. Inflammatory Bowel Disease 1 item
  23. Inflammatory Diseases 3item
  24. Leukemia 7item
  25. Liver Cancer 3item
  26. Lung Cancer 14item
  27. Lung Carcinoma 3item
  28. Lymphoma 9item
  29. Mantle Cell Lymphoma 1 item
  30. Melanoma 10item
  31. Multiple Myeloma 4item
  32. Myelofibrosis 1 item
  33. Myeloma 1 item
  34. Neuroblastoma 2item
  35. Non-small Cell Lung Cancer 5item
  36. Non-small Cell Lung Carcinoma 1 item
  37. Ovarian Cancer 14item
  38. Pancreatic Cancer 22item
  39. Prostate Cancer 14item
  40. Psoriasis 1 item
  41. Pulmonary Arterial Hypertension 1 item
  42. Renal Cancer 3item
  43. Renal Cell Carcinoma 5item
  44. Rheumatoid Arthritis 5item
  45. Thyroid Cancer 5item
  46. Type 2 Diabetes 2item